The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice
A. Peled et al., The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice, BLOOD, 95(11), 2000, pp. 3289-3296
Hematopoietic stem cell homing and engraftment require several adhesion Int
eractions, which are not fully understood. Engraftment of nonobese/severe c
ombined immunodeficiency (NOD/SCID) mice by human stem cells is dependent o
n the major integrins very late activation antigen-4 (VLA-4); VLA-5; and to
a lesser degree, lymphocyte function associated antigen-1 (LFA-1). Treatme
nt of human CD34(+) cells with antibodies to either VLA-4 or VLA-5 prevente
d engraftment, and treatment with anti-LFA-l antibodies significantly reduc
ed the levels of engraftment. Activation of CD34(+) cells, which bear the c
hemokine receptor CXCR4, with stromal derived factor 1 (SDF-1) led to firm
adhesion and transendothelial migration, which was dependent on LFA-1/ICAM-
1 (Intracellular adhesion molecule-1)and VLA-4/VCAM-1 (vascular adhesion mo
lecule-1). Furthermore, SDF1-induced polarization and extravasation of CD34
(+)/CXCR4(+) cells through the extracellular matrix underlining the endothe
lium was dependent on both VLA-4 and VLA-5. Our results demonstrate that re
populating human stem cells functionally express LFA-1, VLA-4, and VLA-5, F
urthermore, this study implies a novel approach to further advance clinical
transplantation.(Blood. 2000;95:3289-3296) (C) 2000 by The American Societ
y of Hematology.